Why is postpartum psychosis central in the Lindsay Clancy trial?
bbc - Lindsay Clancy's defence argues that Clancy was suffering from postpartum psychosis when she killed her children. She has pleaded not guilty to murder.
AI Summary: In the high-profile Lindsay Clancy murder trial, experts and family testimonies focused on postpartum psychosis as a central issue, examining whether the condition influenced actions. Court proceedings featured medical explanations and witness accounts debating culpability and diminished responsibility, spotlighting challenges at the crossroads of psychiatric illness and criminal law — messy and tragic.
Newly found 'immune organ' inside skull directs brain defense
medicalxpress - Researchers at Washington University School of Medicine in St. Louis have discovered lymph node-like structures in the skull bone marrow of mice for the first time and demonstrated that they act as rapid first responders against brain cancer before distan…
AI Summary: Scientists discovered organized immune cell hubs within the skull that communicate directly with the brain, revealing a previously overlooked pathway for neuroimmune surveillance. The structures appear to coordinate responses to infection and injury, offering fresh targets for neurological disease therapies and a neat explanation for why the brain sometimes seems to have its own security detail.
New brain cell formation stalls in adults with depression, study shows
medicalxpress - Findings from a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons suggest that the trickle of neurons created in the adult hippocampus could be instrumental in preventing depression. Most of the brain's 100 billion…
AI Summary: Studies report that adults with major depressive disorder show reduced generation of new neurons in the hippocampus, suggesting impaired adult neurogenesis may underlie persistent symptoms. Findings provide a biological clue to treatment resistance and point toward therapies that could restore brain plasticity — promising, and mildly depressing for depression itself.
Study ties estrogen-based menopausal hormone therapy to lower Alzheimer's risk
medicalxpress - Women on regimens of estrogen-only menopausal hormone therapy are at reduced risk of Alzheimer's disease, a study by Stanford Medicine investigators has found. Because estrogen-only therapy is generally prescribed for women without a uterus, most of these…
AI Summary: Observational research linked estrogen‑based menopausal hormone therapy to fewer Alzheimer’s‑related brain changes on imaging, suggesting a potential protective association. Investigators stress that timing, confounding factors and observational design limit causal claims, so randomized trials and careful risk‑benefit assessment remain necessary before changing clinical practice — or anyone swapping kale for HRT on a whim.
Single dose of psilocybin for depression shows promising results in UK's first publicly funded randomized trial
medicalxpress - The first randomized controlled trial in the U.K. has found that a single dose of psilocybin, the active compound found in "magic mushrooms," produced significant improvements in depression compared with a placebo. This is the first publicly funded random…
AI Summary: A publicly funded randomized trial in the UK found that a single dose of psilocybin, delivered in a clinical setting, produced promising improvements for people with treatment-resistant major depressive disorder. The results suggest psychedelic-assisted therapy could be a viable addition to standard care—pending larger trials and careful safety monitoring—challenging old assumptions about one-and-done fixes.
FDA approves first drug for full range of narcolepsy symptoms
medicalxpress - The U.S. Food and Drug Administration has approved Orzeyful (oveporexton) tablets to treat narcolepsy type 1 in adults. Orzeyful marks the first medication approved for the full range of symptoms associated with narcolepsy type 1 and is the first approved…
AI Summary: The FDA has approved a medication that treats the full range of narcolepsy symptoms, including excessive daytime sleepiness and cataplexy, marking the first such comprehensive option for patients with narcolepsy type 1. Clinicians now have a single, regulated choice to address multiple debilitating symptoms rather than juggling piecemeal therapies.
There are new blood tests for Alzheimer's. Should I have one?
medicalxpress - Australians have seen a flurry of headlines announcing the arrival of blood tests for Alzheimer's disease.
AI Summary: New blood tests detecting Alzheimer’s biomarkers are reaching clinical availability, promising earlier and less invasive diagnosis. Clinicians and consumers now face decisions about who should be tested, how to interpret results, and what interventions — if any — follow a positive biomarker. The tests shift diagnostic practice while raising ethical and counseling challenges.
FDA approves Simtriyo for treating ADHD in children and adults
medicalxpress - The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and children 6 years and older weighing ≥20 kg.
AI Summary: The FDA granted approval for Simtriyo to treat attention‑deficit/hyperactivity disorder in children and adults, adding a new prescription option to the ADHD toolkit. Regulators highlighted efficacy and safety data supporting the decision; clinicians and patients will now weigh the drug’s profile against existing therapies as rollout and coverage decisions play out.
Two Children With a Rare Epilepsy Mutation Show Improvement After Personalized Genetic Treatment
discovermagazine - Learn how personalized genetic therapy helped researchers treat two children with a rare form of epilepsy, enabling one to walk independently for the first time.
AI Summary: Two children with a rare, treatment‑resistant epilepsy mutation showed marked clinical improvement after receiving individualized genetic therapies—one via an antisense oligonucleotide tailored to the mutation. The cases underscore the promise of bespoke molecular medicines for devastating pediatric neurological disorders and hint that precision medicine can be both life‑changing and, yes, kind of miraculous.
New study sheds light on how Epstein-Barr virus may contribute to multiple sclerosis
medicalxpress - Multiple sclerosis (MS) is a chronic autoimmune disorder that attacks the central nervous system. For years, Epstein-Barr virus (EBV) has been strongly linked to MS, as nearly every person diagnosed with the condition shows evidence of past EBV infection.…
AI Summary: Researchers report that immune responses to Epstein‑Barr virus are implicated in multiple sclerosis, with EBV‑reactive CD4+ T cells enriched in people with MS. The work provides mechanistic evidence connecting prior infection to neuroinflammation and suggests antiviral or immune‑directed strategies might be viable prevention or treatment avenues — assuming we like attacking tiny viral culprits.
Genetic study redefines a form of excessive sweating as a treatable neurological condition
medicalxpress - An international research team led by Dr. Frank Bosmans (Vrije Universiteit Brussel) has discovered a major genetic cause of hyperhidrosis (chronic and excessive sweating). The study, published in Science Advances, provides strong evidence that a genetica…
AI Summary: New research identifies a genetic basis and a tiny electrically gated ion channel in nerve cells as drivers of a form of excessive sweating, recasting it as a neurological condition rather than a benign nuisance. Findings point to potential targeted therapies that address the underlying neural mechanism rather than symptom management alone.
Blood-based test can predict risk of developing symptoms of Alzheimer's up to a decade early
medicalxpress - A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about the extent to which such tests can accurately predict whether a cognitively healthy individual will develop cognitive im…
AI Summary: Researchers validated a blood‑based test that flags individuals at elevated risk of developing Alzheimer’s symptoms up to a decade earlier, showing strong predictive accuracy across cohorts. The finding could enable earlier monitoring and trial enrollment, but raises questions about screening protocols, follow‑up care and the psychological burden of long‑lead risk information.
- Blood biomarkers forecast Alzheimer's risk years ahead (4)
- Genetics and clearance mechanisms shaping Alzheimer's onset (3)
- Sleep, frailty and resilience as non-blood early signals (3)
Blood biomarkers forecast Alzheimer's risk years ahead
Genetics and clearance mechanisms shaping Alzheimer's onset
Sleep, frailty and resilience as non-blood early signals
Appeals Court Revives Lawsuits Tying Tylenol Use in Pregnancy to Autism and A.D.H.D.
Azeen Ghorayshi / nytimes - A federal appeals court overruled a district court judge who dismissed the lawsuits, citing unreliable scientific evidence.
AI Summary: An appeals court has revived private lawsuits claiming prenatal acetaminophen exposure is linked to neurodevelopmental disorders such as autism and ADHD, sending scores of cases back into litigation. Plaintiffs allege longstanding product liability and causation questions that will now play out in courtrooms rather than headlines. Legal battles, not medical consensus, will determine next steps.
First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients
medicalxpress - Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged in the past two decades, un…
AI Summary: A first‑in‑human immunotherapy study in recurrent glioblastoma reported a more than twofold improvement in progression‑free survival, drawing attention to anti‑LAG‑3 strategies with or without anti‑PD‑1. While early and limited, the results provide a rare hint of efficacy in a notoriously treatment‑resistant cancer and warrant expedited follow‑up.
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial
Stephanie Gomez / nature - Nature Medicine, Published online: 30 June 2026; doi:10.1038/s41591-026-04449-9In the phase 1 ReMIND trial of tumor-associated antigen-specific T cells in patients with pediatric central nervous system tumors, treatment was generally well tolerated with o…
AI Summary: A phase I trial of multi‑antigen‑targeted T cells for aggressive pediatric CNS tumors reported early survival and safety signals, suggesting these engineered cells can engage heterogeneous tumor antigens. Investigators emphasize cautious optimism: encouraging early responses in a dire setting, but longer follow‑up and larger cohorts are needed before this becomes standard‑of‑care.
Feel Like You're on the Same Wavelength With Someone? Synchrony Is Real, and May be Strengthened
discovermagazine - Learn how brainwave synchrony could help explain why people feel connected and how real-time feedback may strengthen that bond.
AI Summary: Two stories cover the same research showing interpersonal synchrony (alignment of physiology or behavior between people) is measurable and can be enhanced. Experiments demonstrate real-world synchrony in heart rate, brain activity or movement, suggesting applications for therapy and teamwork — and raising the delightful prospect of engineering better human vibes.
Dementia care: Re‑envisioning the role of music
medicalxpress - As a certified music therapist, I have observed firsthand the many ways music can bring meaning and beauty into people's lives, even under very difficult circumstances. Much of my clinical work and research has occurred in dementia care. Here, music is of…
AI Summary: Clinicians and care teams are repositioning music from a pleasant diversion to a core therapeutic tool in dementia care. Targeted music interventions are shown to soothe agitation, trigger memories, support communication and daily routines, and empower caregivers. Programs emphasize personalized playlists, staff training and integrating music into clinical care pathways—because sometimes a song works where a pill does not.
- Care priorities, prevention and sensory supports for dementia (4)
- Music and expressive non-drug therapies in dementia care (4)
Care priorities, prevention and sensory supports for dementia
Music and expressive non-drug therapies in dementia care
Hibernation-like cooling after stroke may reduce brain damage
medicalxpress - Our body loves the state of homeostasis, where everything is in perfect equilibrium, from temperature to pH levels to fluid balance. As soon as the body's core temperature drops below 95°F (35°C) and stays there for a long time, the heart, nervous system …
AI Summary: Researchers report that inducing a hibernation-like state via drugs and controlled cooling can reduce brain damage after ischemic stroke in preclinical and early clinical work, limiting infarct size, dampening inflammation and improving functional outcomes. The approach shows translational potential but requires carefully designed trials to confirm safety and efficacy.
Robert Coles, Pulitzer-Winning Child Psychiatrist, Is Dead at 97
Douglas Martin / nytimes - His five-volume “Children of Crisis” series, published between 1967 and 1977, drew on his conversations with American children whose voices were not often heard.
AI Summary: Robert Coles, the Pulitzer Prize–winning psychiatrist and author who spent a career championing children’s emotional needs and humane care, has died at 97. A towering voice in child psychiatry and moral medicine, Coles blended literature and clinical insight to influence policy, training and public understanding — leaving a legacy that critics and admirers alike will continue to debate.
Implanted radiation device cuts brain tumor recurrence: 5 study notes
Ella Jeffries / beckershospitalreview - An implanted radiation device has improved tumor control and overall survival compared with standard radiation therapy in patients with newly diagnosed operable brain metastases, according to phase 3 clinical trial data presented May 30 at the American So…
AI Summary: Clinical trial data show an implanted "tile" radiation device placed at resection sites lowers local recurrence risk for patients with brain metastases. The approach provides a targeted, intraoperative boost that shortens treatment timelines — and gives surgeons one more tool to argue they cured something before the tumor disagreed.